Intellectual Property India Publishes Patent Application for 'Antibody Or Antigen-Binding Fragment Thereof' Filed by Karydo Therapeutix, Inc.

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517085574 A) filed by Karydo Therapeutix, Inc., Tokyo, on Sept. 9, for 'antibody or antigen-binding fragment thereof.'

Inventor(s) include Sato, Narutoku.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "The present invention addresses the problem of providing an antibody capable of detecting human PRB1 protein in not only saliva but also in serum. Said problem is solved by: an antibody which has the ability to bind to human PRB1 protein and in which a heavy chain variable region has an amino acid sequence having an identity of 95% or more with respect to a heavy chain variable region represented by an amino acid sequence from no. 19 to no. 132 in SEQ ID NO: 1, and a light chain variable region has an amino acid sequence having an identity of 95% or more with respect to a light chain variable region represented by an amino acid sequence from no. 21 to no. 132 in SEQ ID NO: 6; or an antigen-binding fragment of the antibody."

The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/JP2024/007913.

Disclaimer: Curated by HT Syndication.